πŸ‡ΊπŸ‡Έ FDA
Patent

US 9918939

Formulation of Syk inhibitors

granted A61KA61K31/5377A61K47/10

Quick answer

US patent 9918939 (Formulation of Syk inhibitors) held by GILEAD CONNECTICUT, INC. expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/5377, A61K47/10, A61K47/38, A61K9/2027